-They have reduced or eliminated co-pays so no patient is paying as much out of pocket as they used to
-The drug is still 50% given away to people who cannot afford it
-The company ships drugs to patients before resolving disputes with insurance providers
-Shkreli's view is that it is in the best long term interests of the public to have a drug that can be insanely profitable be insanely profitable because it creates an incentive to create another better drug
-On that line, the company is researching new alternatives to the drug which are less toxic (ie: cannabalizing its own market)
Maybe they will create a new drug with the extra money, but there is no reason to believe a generic drug manufacturer has anything in the way of research capability to do so. There is no reason to view this as anything but bullshit.
He had the company switch over to direct sales, which explains most every other point.
The only thing to note here is that they raised the price 5000% for a drug from the 40s.